Skip Navigation



IJE Advance Access published online on May 26, 2004

International Journal of Epidemiology, doi:10.1093/ije/dyh046
© 2004 by International Epidemiological Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/3/596    most recent
dyh046v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Int. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kjaer, S. K.
Right arrow Articles by Olsen, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kjaer, S. K.
Right arrow Articles by Olsen, J. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Accepted October 6, 2003

Original paper

Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women

Susanne K. Kjaer 1*, Lene Mellemkjaer 1, Louise A. Brinton 2, Christoffer Johansen 1, Gloria Gridley 2, Jørgen H. Olsen 1

1 Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark
2 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

* To whom correspondence should be addressed. E-mail: susanne{at}cancer.dk.


   Abstract

Background On the basis of a population-based cohort, we assessed the cancer risk, focusing on gynaecological cancers and pre-malignant lesions, among women with a previous tubal sterilization.

Methods Using the Danish Hospital Discharge Register we identified 65 232 women who had a tubal sterilization (1977-1993). The cohort was followed for cancer occurrence, and compared with the expected number based on the national cancer incidence rates.

Results The overall risk of ovarian cancer was decreased (standardized incidence ratio [SIR] = 0.82; 95% CI: 0.6, 1.0), and it was still decreased >=10 years after the sterilization (SIR = 0.65; 95% CI: 0.4, 1.0). The rate of endometrial cancer was also decreased (SIR = 0.66; 95% CI: 0.5, 1.0), the risk continued being moderately reduced during follow-up, although it was not statistically significant.

Conclusions In this nationwide, population-based study we find that women with tubal sterilization have a decreased risk of subsequent development of ovarian cancer. As the protective effect is not decreasing with years of follow-up, our data do not support that ‘screening’ bias can explain the protective effect, but indicate that the sterilization itself may convey a reduction in risk. The same pattern is found for endometrial cancer, the association being less strong.

Keywords Tubal sterilization, cohort study, risk, gynaecological cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Int. J. Epidemiol.:

Commentary: Does tubal sterilization reduce the risk of gynaecological cancers?
David M. Purdie
Int. J. Epidemiol. 2004 10.1093/ije/dyh119. [PDF]  



This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Reid, A. Segal, J. S. Heyworth, N. H. de Klerk, and A. W. Musk
Gynecologic and Breast Cancers in Women After Exposure to Blue Asbestos at Wittenoom
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
H. A. Abenhaim, L. Titus-Ernstoff, and D. W. Cramer
Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider
Can. Med. Assoc. J., March 27, 2007; 176(7): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Terry, L. Titus-Ernstoff, J. R. McKolanis, W. R. Welch, O. J. Finn, and D. W. Cramer
Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 30 - 35.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.